Cosmos Health Inc. (COSM)
COSM moved a median of 0.00% 30 minutes after news, and -0.33% by the close. How COSM actually reacts to news — the realized, point-in-time move the market made, measured across 450 labeled events over the last three years with zero look-ahead.
COSM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 48% | 436 |
| 30-min | 0.00% | 50% | 445 |
| 60-min | 0.00% | 49% | 446 |
| to close | -0.33% | 45% | 444 |
| Middle 50% of COSM reactions | -2.30% to +2.11% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 450 |
Half of all Cosmos Health Inc. news events land between -2.30% and +2.11% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when COSM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to COSM's baseline. Nothing else.
Recent COSM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Cosmos Health Inc. For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +4.87% | — | |
| Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million | Press release | ACCESS Newswire | +3.37% | +1.87% | |
| Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion | Press release | ACCESS Newswire | -0.77% | -0.77% | |
| Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue | Press release | ACCESS Newswire | +4.38% | +9.84% | |
| Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline | Press release | ACCESS Newswire | +2.67% | +2.83% | |
| Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June | Press release | ACCESS Newswire | +1.06% | +1.76% | |
| Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market | Press release | ACCESS Newswire | +2.24% | +2.24% | |
| Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units | Press release | ACCESS Newswire | -0.55% | -6.80% | |
| Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market | Press release | ACCESS Newswire | +0.51% | -7.74% | |
| Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories | Press release | GlobeNewswire | +4.39% | +0.68% | |
| Form 8-K Cosmos Health Inc. For: Aug 19 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.65% | |
| Form 10-Q Cosmos Health Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -5.08% | -1.03% | |
| Form NT 10-Q Cosmos Health Inc. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | -0.95% | -6.82% | |
| Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels | Press release | GlobeNewswire | +0.31% | +5.66% | |
| Form RW Cosmos Health Inc. | SEC filing · Form RW | SEC EDGAR | +1.81% | -1.34% | |
| Form S-8 Cosmos Health Inc. | SEC filing · Form S-8 | SEC EDGAR | +3.83% | +0.13% | |
| Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases | Press release | GlobeNewswire | +0.51% | +1.30% | |
| Form 8-K Cosmos Health Inc. For: Jul 15 | SEC filing · Form 8-K | SEC EDGAR | +0.70% | -13.04% | |
| Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases | Press release | GlobeNewswire | +0.57% | -0.07% | |
| Cosmos Health Launches Subscription Model | Press release | GlobeNewswire | +5.52% | +15.78% | |
| Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases | Press release | GlobeNewswire | +0.24% | +4.72% | |
| Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases | Press release | GlobeNewswire | -0.83% | +1.78% | |
| Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases | Press release | GlobeNewswire | +7.34% | +1.91% | |
| Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases | Press release | GlobeNewswire | +2.87% | +3.21% | |
| Form 8-K Cosmos Health Inc. For: Jun 30 | SEC filing · Form 8-K | SEC EDGAR | +0.10% | +12.09% | |
| Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace | Press release | GlobeNewswire | +2.04% | +8.27% | |
| Cosmos Health Authorizes Up to $5 Million Share Repurchase Program | Press release | GlobeNewswire | +4.31% | +8.94% | |
| Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units | Press release | GlobeNewswire | +5.35% | -7.82% | |
| Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada | Press release | GlobeNewswire | +0.36% | -3.39% | |
| Cosmos Health’s C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin | Press release | GlobeNewswire | +2.29% | +3.79% | |
| Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency | Press release | GlobeNewswire | +1.97% | +2.17% | |
| CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity | Press release | GlobeNewswire | +4.05% | +9.83% | |
| Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States | Press release | GlobeNewswire | +1.67% | +0.71% | |
| Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit | Press release | GlobeNewswire | -7.11% | +10.90% | |
| Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines | Press release | GlobeNewswire | +1.10% | +0.62% | |
| Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance | Press release | GlobeNewswire | +1.57% | -1.91% | |
| Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio | Press release | GlobeNewswire | +4.57% | +3.41% | |
| Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries | Press release | GlobeNewswire | +10.48% | +14.39% | |
| Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN | Press release | GlobeNewswire | +2.13% | -0.80% | |
| Form S-3/A Cosmos Health Inc. | SEC filing · Form S-3 | SEC EDGAR | -2.40% | -8.11% | |
| Form DEFA14A Cosmos Health Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -2.40% | -8.11% | |
| Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz | Press release | GlobeNewswire | +0.91% | +0.91% | |
| Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value | Press release | GlobeNewswire | -3.46% | +4.19% | |
| Form DEF 14A Cosmos Health Inc. For: Jun 02 | SEC filing · Form DEF | SEC EDGAR | -6.29% | -8.19% | |
| Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657 | Press release | GlobeNewswire | -1.89% | -2.81% | |
| Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation | Press release | GlobeNewswire | -1.27% | -2.16% | |
| Form 8-K Cosmos Health Inc. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | -1.29% | -4.36% | |
| Form PRE 14A Cosmos Health Inc. For: May 22 | SEC filing · Form PRE | SEC EDGAR | +4.09% | -2.38% | |
| Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants | Press release | ACCESS Newswire | +0.04% | +1.71% | |
| Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway | Press release | ACCESS Newswire | -3.49% | -7.13% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the COSM section they belong to.
Where else COSM is measured.
COSM earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TERRASCENT CORP (TRSSF) | 453 | -0.04% | 44% |
| Glaukos Corporation (GKOS) | 452 | +0.04% | 51% |
| ROCHE HOLDING LTD S/ADR (RHHBY) | 449 | +0.03% | 52% |
| CareDx, Inc. (CDNA) | 443 | -0.11% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cosmos Health Inc.'s median reaction calculated?
Every labeled COSM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 450 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of COSM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does COSM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.